Impact of COVID-19 on skin conditions in healthcare workers
Impact of Covid-19 on Occupational Dermato-allergology Consultations of Health Peronnel
This study looks at how the COVID-19 pandemic has affected skin problems in healthcare workers, especially those caused by wearing protective gear and using more hygiene products.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 471 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Centre Hospitalier Intercommunal Creteil Academic / other |
| Locations | 1 site (Paris) |
| Trial ID | NCT06237010 on ClinicalTrials.gov |
What this trial studies
This observational study analyzes the effects of the COVID-19 pandemic on occupational dermatitis among healthcare workers in the Paris region. By examining data from two specialized centers, the study aims to assess changes in dermatology-allergology consultations before and after the pandemic. It focuses on the incidence of work-related allergic contact dermatitis and other dermatoses linked to increased use of personal protective equipment and hygiene products. The study seeks to fill a significant knowledge gap regarding the prevalence of these conditions during the pandemic.
Who should consider this trial
Good fit: Ideal candidates for this study are healthcare workers who have consulted for occupational dermato-allergological issues for the first time between March 15, 2017, and March 15, 2023.
Not a fit: Patients who have not consulted for occupational dermato-allergological problems or those without active healthcare roles may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the prevalence and impact of occupational dermatitis among healthcare workers, leading to improved prevention and management strategies.
How similar studies have performed: While there is limited recent data on this specific topic, similar studies have highlighted the prevalence of occupational dermatitis, suggesting that this approach could yield meaningful insights.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients who consulted for the first time between 15th march 2017 and 15th march 2023 for an occupational dermato-allergological problem ; * Active subjects and occupying a health personnel position defined according to the Public Health Code ; * Over 18 years old at the first consultation, with no upper limit * Having not expressed their opposition to participate in the study. Exclusion Criteria: * Patients who consulted for an other problem than occupational dermato-allergological problem ; * Patients who not consulted for the first time between 15th march 2017 and 15th march 2023. * Patients without occupational activity the day of the first consultation * Patients who opposite to participation in the study
Where this trial is running
Paris
- Hôpital Hôtel Dieu — Paris, France (Recruiting)
Study contacts
- Study coordinator: Marie-Thérèse LE CAM, Dr
- Email: marie-therese.lecam@chicreteil.fr
- Phone: 0157022074
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.